Protective role of MyD88-independent innate immune responses against prion infection

References

• Prusiner SB. Prions. Proc Natl Acad Sci U S A 1998; 95:13363 - 83; http://dx.doi.org/10.1073/pnas.95.23.13363; PMID: 9811807
   PubMed Web of Science ®Google Scholar
• Aguzzi A, Heikenwalder M, Polymenidou M. Insights into prion strains and neurotoxicity. Nat Rev Mol Cell Biol 2007; 8:552 - 61; http://dx.doi.org/10.1038/nrm2204; PMID: 17585315
   PubMed Web of Science ®Google Scholar
• Manuelidis L. Vaccination with an attenuated Creutzfeldt-Jakob disease strain prevents expression of a virulent agent. Proc Natl Acad Sci U S A 1998; 95:2520 - 5; http://dx.doi.org/10.1073/pnas.95.5.2520; PMID: 9482918
   PubMed Web of Science ®Google Scholar
• Nishida N, Katamine S, Manuelidis L. Reciprocal interference between specific CJD and scrapie agents in neural cell cultures. Science 2005; 310:493 - 6; http://dx.doi.org/10.1126/science.1118155; PMID: 16239476
   PubMed Web of Science ®Google Scholar
• Katz M, Koprowski H. Failure to demonstrate a relationship between scrapie and production of interferon in mice. Nature 1968; 219:639 - 40; http://dx.doi.org/10.1038/219639a0; PMID: 5691075
   PubMed Web of Science ®Google Scholar
• Field EJ, Joyce G, Keith A. Failure of interferon to modify scrapie in the mouse. J Gen Virol 1969; 5:149 - 50; http://dx.doi.org/10.1099/0022-1317-5-1-149; PMID: 5387845
   PubMed Web of Science ®Google Scholar
• Gresser I, Maury C, Chandler RL. Failure to modify scrapie in mice by administration of interferon or anti-interferon globulin. J Gen Virol 1983; 64:1387 - 9; http://dx.doi.org/10.1099/0022-1317-64-6-1387; PMID: 6189965
   PubMed Web of Science ®Google Scholar
• Worthington M. Interferon system in mice infected with the scrapie agent. Infect Immun 1972; 6:643 - 5; PMID: 4628902
   PubMed Web of Science ®Google Scholar
• Baker CA, Lu ZY, Manuelidis L. Early induction of interferon-responsive mRNAs in Creutzfeldt-Jakob disease. J Neurovirol 2004; 10:29 - 40; http://dx.doi.org/10.1080/13550280490261761; PMID: 14982726
   PubMed Web of Science ®Google Scholar
• Field R, Campion S, Warren C, Murray C, Cunningham C. Systemic challenge with the TLR3 agonist poly I:C induces amplified IFNalpha/beta and IL-1beta responses in the diseased brain and exacerbates chronic neurodegeneration. Brain Behav Immun 2010; 24:996 - 1007; http://dx.doi.org/10.1016/j.bbi.2010.04.004; PMID: 20399848
   PubMed Web of Science ®Google Scholar
• Riemer C, Queck I, Simon D, Kurth R, Baier M. Identification of upregulated genes in scrapie-infected brain tissue. J Virol 2000; 74:10245 - 8; http://dx.doi.org/10.1128/JVI.74.21.10245-10248.2000; PMID: 11024157
   PubMed Web of Science ®Google Scholar
• Stobart MJ, Parchaliuk D, Simon SL, Lemaistre J, Lazar J, Rubenstein R, et al. Differential expression of interferon responsive genes in rodent models of transmissible spongiform encephalopathy disease. Mol Neurodegener 2007; 2:5; http://dx.doi.org/10.1186/1750-1326-2-5; PMID: 17367538
   PubMed Web of Science ®Google Scholar
• Xiang W, Windl O, Wünsch G, Dugas M, Kohlmann A, Dierkes N, et al. Identification of differentially expressed genes in scrapie-infected mouse brains by using global gene expression technology. J Virol 2004; 78:11051 - 60; http://dx.doi.org/10.1128/JVI.78.20.11051-11060.2004; PMID: 15452225
   PubMed Web of Science ®Google Scholar
• Takeuchi O, Akira S. Genetic approaches to the study of Toll-like receptor function. Microbes Infect 2002; 4:887 - 95; http://dx.doi.org/10.1016/S1286-4579(02)01615-5; PMID: 12106781
   PubMed Web of Science ®Google Scholar
• Seth RB, Sun L, Chen ZJ. Antiviral innate immunity pathways. Cell Res 2006; 16:141 - 7; http://dx.doi.org/10.1038/sj.cr.7310019; PMID: 16474426
   PubMed Web of Science ®Google Scholar
• Honda K, Taniguchi T. IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat Rev Immunol 2006; 6:644 - 58; http://dx.doi.org/10.1038/nri1900; PMID: 16932750
   PubMed Web of Science ®Google Scholar
• Samanta M, Iwakiri D, Takada K. Epstein-Barr virus-encoded small RNA induces IL-10 through RIG-I-mediated IRF-3 signaling. Oncogene 2008; 27:4150 - 60; http://dx.doi.org/10.1038/onc.2008.75; PMID: 18362887
   PubMed Web of Science ®Google Scholar
• Tal Y, Souan L, Cohen IR, Meiner Z, Taraboulos A, Mor F. Complete Freund’s adjuvant immunization prolongs survival in experimental prion disease in mice. J Neurosci Res 2003; 71:286 - 90; http://dx.doi.org/10.1002/jnr.10474; PMID: 12503092
   PubMed Web of Science ®Google Scholar
• Sethi S, Lipford G, Wagner H, Kretzschmar H. Postexposure prophylaxis against prion disease with a stimulator of innate immunity. Lancet 2002; 360:229 - 30; http://dx.doi.org/10.1016/S0140-6736(02)09513-2; PMID: 12133662
   PubMed Web of Science ®Google Scholar
• Cunningham C, Wilcockson DC, Campion S, Lunnon K, Perry VH. Central and systemic endotoxin challenges exacerbate the local inflammatory response and increase neuronal death during chronic neurodegeneration. J Neurosci 2005; 25:9275 - 84; http://dx.doi.org/10.1523/JNEUROSCI.2614-05.2005; PMID: 16207887
   PubMed Web of Science ®Google Scholar
• Prinz M, Heikenwalder M, Schwarz P, Takeda K, Akira S, Aguzzi A. Prion pathogenesis in the absence of Toll-like receptor signalling. EMBO Rep 2003; 4:195 - 9; http://dx.doi.org/10.1038/sj.embor.embor731; PMID: 12612611
   PubMed Web of Science ®Google Scholar
• Spinner DS, Cho IS, Park SY, Kim JI, Meeker HC, Ye X, et al. Accelerated prion disease pathogenesis in Toll-like receptor 4 signaling-mutant mice. J Virol 2008; 82:10701 - 8; http://dx.doi.org/10.1128/JVI.00522-08; PMID: 18715916
   PubMed Web of Science ®Google Scholar
• Burwinkel M, Schwarz A, Riemer C, Schultz J, van Landeghem F, Baier M. Rapid disease development in scrapie-infected mice deficient for CD40 ligand. EMBO Rep 2004; 5:527 - 31; http://dx.doi.org/10.1038/sj.embor.7400125; PMID: 15071493
   PubMed Web of Science ®Google Scholar
• Delhaye S, Paul S, Blakqori G, Minet M, Weber F, Staeheli P, et al. Neurons produce type I interferon during viral encephalitis. Proc Natl Acad Sci U S A 2006; 103:7835 - 40; http://dx.doi.org/10.1073/pnas.0602460103; PMID: 16682623
   PubMed Web of Science ®Google Scholar
• Au WC, Moore PA, Lowther W, Juang YT, Pitha PM. Identification of a member of the interferon regulatory factor family that binds to the interferon-stimulated response element and activates expression of interferon-induced genes. Proc Natl Acad Sci U S A 1995; 92:11657 - 61; http://dx.doi.org/10.1073/pnas.92.25.11657; PMID: 8524823
   PubMed Web of Science ®Google Scholar
• Karpova AY, Howley PM, Ronco LV. Dual utilization of an acceptor/donor splice site governs the alternative splicing of the IRF-3 gene. Genes Dev 2000; 14:2813 - 8; http://dx.doi.org/10.1101/gad.813800; PMID: 11090129
   PubMed Web of Science ®Google Scholar
• Zhai J, Gao D, Liu W, Hong R, Qin Y, Ouyang H, et al. Characterization of a novel isoform of murine interferon regulatory factor 3. Biochem Biophys Res Commun 2008; 377:384 - 8; http://dx.doi.org/10.1016/j.bbrc.2008.09.147; PMID: 18851954
   PubMed Web of Science ®Google Scholar
• Yokota S, Yokosawa N, Okabayashi T, Suzutani T, Miura S, Jimbow K, et al. Induction of suppressor of cytokine signaling-3 by herpes simplex virus type 1 contributes to inhibition of the interferon signaling pathway. J Virol 2004; 78:6282 - 6; http://dx.doi.org/10.1128/JVI.78.12.6282-6286.2004; PMID: 15163721
   PubMed Web of Science ®Google Scholar
• Ménager P, Roux P, Mégret F, Bourgeois JP, Le Sourd AM, Danckaert A, et al. Toll-like receptor 3 (TLR3) plays a major role in the formation of rabies virus Negri Bodies. PLoS Pathog 2009; 5:e1000315; http://dx.doi.org/10.1371/journal.ppat.1000315; PMID: 19247444
   PubMed Web of Science ®Google Scholar
• Ishibashi D, Atarashi R, Fuse T, Nakagaki T, Yamaguchi N, Satoh K, et al. Protective role of interferon regulatory factor 3-mediated signaling against prion infection. J Virol 2012; 86:4947 - 55; http://dx.doi.org/10.1128/JVI.06326-11; PMID: 22379081
   PubMed Web of Science ®Google Scholar
• Hata N, Sato M, Takaoka A, Asagiri M, Tanaka N, Taniguchi T. Constitutive IFN-alpha/beta signal for efficient IFN-alpha/beta gene induction by virus. Biochem Biophys Res Commun 2001; 285:518 - 25; http://dx.doi.org/10.1006/bbrc.2001.5159; PMID: 11444873
   PubMed Web of Science ®Google Scholar
• Taniguchi T, Takaoka A. A weak signal for strong responses: interferon-alpha/beta revisited. Nat Rev Mol Cell Biol 2001; 2:378 - 86; http://dx.doi.org/10.1038/35073080; PMID: 11331912
   PubMed Web of Science ®Google Scholar
• Chen HM, Tanaka N, Mitani Y, Oda E, Nozawa H, Chen JZ, et al. Critical role for constitutive type I interferon signaling in the prevention of cellular transformation. Cancer Sci 2009; 100:449 - 56; http://dx.doi.org/10.1111/j.1349-7006.2008.01051.x; PMID: 19076978
   PubMed Web of Science ®Google Scholar
• Thackray AM, McKenzie AN, Klein MA, Lauder A, Bujdoso R. Accelerated prion disease in the absence of interleukin-10. J Virol 2004; 78:13697 - 707; http://dx.doi.org/10.1128/JVI.78.24.13697-13707.2004; PMID: 15564479
   PubMed Web of Science ®Google Scholar
• Tamgüney G, Giles K, Glidden DV, Lessard P, Wille H, Tremblay P, et al. Genes contributing to prion pathogenesis. J Gen Virol 2008; 89:1777 - 88; http://dx.doi.org/10.1099/vir.0.2008/001255-0; PMID: 18559949
   PubMed Web of Science ®Google Scholar